In Vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced from Plasma of COVID-19 Convalescent Donors by GLACIER | Jan 5, 2022 | Immunology, Publications Full Paper
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles by GLACIER | Dec 1, 2021 | Bioactive Compounds, Publications Full Article
High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern by GLACIER | Sep 6, 2021 | Immunology, Publications Full Article
